🇺🇸 FDA
Pipeline program

Descartes 30

DC30-1A

Phase 1 mab terminated

Quick answer

Descartes 30 for Acute Respiratory Distress Syndrome is a Phase 1 program (mab) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cartesian Therapeutics
Indication
Acute Respiratory Distress Syndrome
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials